ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab and Retinal Vascular Occlusions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00347711
Recruitment Status : Unknown
Verified June 2006 by Asociación para Evitar la Ceguera en México.
Recruitment status was:  Recruiting
First Posted : July 4, 2006
Last Update Posted : July 4, 2006
Sponsor:
Information provided by:
Asociación para Evitar la Ceguera en México

Brief Summary:
To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.

Condition or disease Intervention/treatment Phase
Edema Macular Vascular Occlusion Drug: Intravitreal injection Phase 3

Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Edema





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography

Exclusion Criteria:

  • Previous surgery
  • Uveitis
  • Glaucoma

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00347711


Locations
Mexico
Asociacion para Evitar la Ceguera en Mexico Recruiting
Mexico, D.F. Mexico, Mexico, 04030
Contact: Griselda Alvarez, Fellow    5255 10841400 ext 1171    retinamex@yahoo.com.   
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Investigators
Principal Investigator: Griselda Alvarez, Fellow APEC

ClinicalTrials.gov Identifier: NCT00347711     History of Changes
Other Study ID Numbers: APEC-0020
First Posted: July 4, 2006    Key Record Dates
Last Update Posted: July 4, 2006
Last Verified: June 2006

Additional relevant MeSH terms:
Macular Edema
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases